Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Collegium Pharmaceutical, Inc (COLL)  
$31.68 0.10 (0.32%) as of 4:30 Fri 6/21


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 41,504,000
Market Cap: 1.31(B)
Last Volume: 0 Avg Vol: 0
52 Week Range: $21.16 - $40.91
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  625
Guru Rank Value     : 3
Guru Occurances    : 1

 

            6 Months   1 Year   2 Year  
 
Company Profile   Collegium Pharmaceutical is a pharmaceutical company. Co.'s portfolio includes: Xtampza ER, Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol. Xtampza ER was approved by the U.S. Food and Drug Administration for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment. Nucynta ER is indicated for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment, including neuropathic pain associated with diabetic peripheral neuropathy in adults. Nucynta IR is indicated for the management of acute pain severe enough to require an opioid analgesic.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 181,711 216,266 332,975 1,049,160
Total Sell Value $6,087,407 $7,248,776 $10,506,887 $26,725,036
Total People Sold 4 5 6 7
Total Sell Transactions 5 8 14 44
End Date 2024-03-24 2023-12-22 2023-06-23 2022-06-23

   
Records found: 391
  Page 15 of 16  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Brannelly Paul Executive Vice President & CFO   •       –      –    2017-02-10 4 A $0.00 $0 D/D 16,250 100,615     -
   Fleming Alison B Chief Technology Officer   •       –      –    2017-02-10 4 A $0.00 $0 D/D 16,250 24,701     -
   Heffernan Michael Thomas Chairman, President and CEO   •       •      –    2017-02-10 4 A $0.00 $0 D/D 55,000 610,555     -
   Duke Barry S See remarks   •       –      –    2017-02-10 4 A $0.00 $0 D/D 13,750 20,475     -
   Heffernan Michael Thomas Chairman, President and CEO   •       •      –    2017-01-31 4 OE $0.48 $1,446 D/D 3,013 555,555     -
   Brannelly Paul Executive Vice President & CFO   •       –      –    2017-01-27 4 A $10.08 $10,140 D/D 1,006 84,365     -
   Fleming Alison B Chief Technology Officer   •       –      –    2017-01-27 4 A $10.08 $12,499 D/D 1,240 8,451     -
   Duke Barry S See remarks   •       –      –    2017-01-27 4 A $10.08 $8,407 D/D 834 6,725     -
   Heffernan Michael Thomas Chairman, President and CEO   •       •      –    2017-01-27 4 A $10.08 $12,489 D/D 1,239 552,542     -
   Fleming Alison B Chief Scientific OfficerOffice   •       –      –    2017-01-04 3 IO $0.00 $0 D/D 0 7,211     -
   Fallon John A. Director   –       •      –    2016-08-12 4 B $10.59 $25,151 D/D 2,375 2,375 2.39     -
   Brannelly Paul Executive Vice President & CFO   •       –      –    2016-07-29 4 A $10.31 $10,135 D/D 983 83,359     -
   Heffernan Michael Thomas Chairman, President and CEO   •       •      –    2016-07-29 4 A $10.31 $12,496 D/D 1,212 551,303     -
   Duke Barry S See remarks   •       –      –    2016-07-29 4 A $10.31 $10,083 D/D 978 5,891     -
   Brannelly Paul Executive Vice President & CFO   •       –      –    2016-05-20 4 A $16.89 $18,579 D/D 1,100 82,376     -
   Brannelly Paul Executive Vice President & CFO   •       –      –    2016-05-18 4 A $16.00 $14,400 D/D 900 81,276     -
   Brannelly Paul Executive Vice President & CFO   •       –      –    2016-05-17 4 A $15.46 $15,460 D/D 1,000 80,376     -
   Brannelly Paul Executive Vice President & CFO   •       –      –    2016-05-16 4 A $15.73 $12,584 D/D 800 79,376     -
   Brannelly Paul Executive Vice President & CFO   •       –      –    2016-05-13 4 A $15.02 $18,024 D/D 1,200 78,576     -
   Heffernan Michael Thomas Chairman, President and CEO   •       •      –    2016-04-05 4 OE $0.48 $33,905 D/D 13,604 387,048     -
   Duke Barry S See remarks   •       –      –    2016-01-20 4 A $0.00 $0 D/D 4,913 4,913     -
   Heffernan Michael Thomas Chairman, President and CEO   •       •      –    2016-01-20 4 A $0.00 $0 D/D 18,135 373,444     -
   Brannelly Paul Executive Vice President & CFO   •       –      –    2016-01-20 4 A $0.00 $0 D/D 4,913 77,376     -
   Enright Patrick G 10% Owner   –       –       •   2015-05-12 4 B $12.00 $2,400,000 I/I 200,000 65,270 1.5     -
   Enright Patrick G 10% Owner   –       –       •   2015-05-12 4 A $0.00 $0 I/I 3,121,842 61,340     -
  391 Records found
  Previous  10  11  12  13  14  15  16   
  Page 15 of 16
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us